Yong Lin Huang

Dr. Yong Lin Huang

Barth Syndrome Foundation, Larchmont, New York, USA
orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 March 2019 in Developmental Psychobiology
Verified
Journal Article
Closed access
PDF file
JHJianzhong Hu
Jianzhong Hu
JLJenny Ly
Jenny Ly
WZWei Zhang
Wei Zhang
Yong Lin HuangYong Lin Huang
Yong Lin Huang
VGVivette Glover
Vivette Glover
YNYoko Jane Nomura
Yoko Jane Nomura

5 February 2019 in Infant Mental Health Journal: Infancy and Early Childhood
Verified
Journal Article
Closed access
PDF file
YNYoko Jane Nomura
Yoko Jane Nomura
KDKei Davey
Kei Davey
PPPatricia M. Pehme
Patricia M. Pehme
JFJackie Finik
Jackie Finik
VGVivette Glover
Vivette Glover
JHJacob Ham
Jacob Ham

11 July 2016 in Journal of Psychopathology and Behavioral Assessment
Verified
Journal Article
Closed access
PDF file
YGYu Gao
Yu Gao
Yong Lin HuangYong Lin Huang
Yong Lin Huang
XLXiaobo Li
Xiaobo Li

9 February 2018 in Journal of Neuroendocrinology
Verified
Journal Article
Closed access
PDF file
WZWei Zhang
Wei Zhang
QLQ. Li
Q. Li
MDM. Deyssenroth
M. Deyssenroth
LLLambertini Luca
Lambertini Luca
JFJ. Finik
J. Finik
YNYoko Jane Nomura
Yoko Jane Nomura

17 June 2025 in JMIR mHealth and uHealth
Verified
Journal Article
Open access
JDJennifer Duffecy
Jennifer Duffecy
ARArfa Rehman
Arfa Rehman
SGScott Gorman
Scott Gorman
Yong Lin HuangYong Lin Huang
Yong Lin Huang
HKHeide Klumpp
Heide Klumpp
Background: Perimenopausal and menopausal symptoms affect many women’s well-being and quality of life. Digital technologies, especially smartphones, allow self-management interventions for menopausal symptoms, but they are understudied. Objective: We evaluated whether a novel digital care app, Caria, effectively reduced vasomotor and behavioral health symptoms of menopause. Methods: We enrolled 149 women for a 6-week randomized controlled trial (app treatment: n=112; web-based educational control: n=37). Enrolled participants had problematic vasomotor symptoms and at least one elevated behavioral health symptom (depression, anxiety, or sleep issues). Web-based self-reported assessments (Hot Flush Rating Scale [HFRS], Patient Health Questionnaire Depression Scale-8 [PHQ-8], Generalized Anxiety Disorder-7, and Pittsburgh Sleep Quality Index [PSQI]) were conducted at baseline, 3 weeks, and 6 weeks. Results: For hot flash severity (HFRS; treatment baseline mean 16.4, SD 6.7 to 6-wk mean 13.6, SD 6.6; control: baseline mean 19.1, SD 7.3 to 6-wk mean 17.8, SD 7.2), a repeated-measures ANOVA revealed main effects for time (F2,262=9.82; P<.001) and treatment arm (F1,131=6.08; P=.01) and a significant time × treatment arm interaction (F2,262=3.23; P=.04); the treatment arm showed lower hot flash severity than the control arm (t147=2.72; P=.007). For depression scores (PHQ-8; treatment baseline mean 14.0, SD 3.8 to 6-wk mean 11.2, SD 5.3; control baseline mean 15.0, SD 3.7 to 6-wk mean 13.4, SD 4.1), a repeated-measures ANOVA showed a main effect of time in the treatment arm (F2,96=15.2; P<.001) but not the control arm (F2,40=2.0; P=.15). Follow-up 2-tailed paired t tests in the treatment arm showed depression decreased from baseline to week 3 (t49=3.3; P=.002) and from weeks 3 to 6 (t48=2.3; P=.02). For sleep quality scores (PSQI; treatment baseline mean 10.7, SD 3.1 to 6-wk mean 10.0, SD 3.5; control baseline mean 11.5, SD 3.7 to 6-wk mean 11.0, SD 3.7), the repeated-measures ANOVA showed a main effect of time in the treatment arm (F2,186=7.8; P=.001) but not the control arm (F2,62=1.3; P=.28). Follow-up 2-tailed paired t tests in the treatment arm showed a significant decrease in sleep issues from baseline to week 3 (t95=3.9; P<.001) but no change from weeks 3 to 6 (t93=0.2; P=.81). Participants with elevated anxiety symptoms showed decreased symptoms in both the treatment and control groups. App engagement was high (average logins over 6 weeks: 53.2). Conclusions: The findings highlight the potential of digital interventions for mitigating menopausal vasomotor and behavioral health symptoms. Significant improvements in the intervention group underscore the app’s effectiveness in providing relief from some of the most challenging aspects of menopause. This study contributes to the evidence supporting digital health interventions in managing menopausal symptoms, presenting a promising avenue for accessible and scalable solutions for women in midlife.

21 January 2020 in Archives of Gynecology and Obstetrics
Verified
Journal Article
Closed access
PDF file
Yong Lin HuangYong Lin Huang
Yong Lin Huang
WZWei Zhang
Wei Zhang
KGKaren Go
Karen Go
KTKenji J. Tsuchiya
Kenji J. Tsuchiya
JHJianzhong Hu
Jianzhong Hu
YNYoko Jane Nomura
Yoko Jane Nomura